Heart Transplantation: Immunological Challenges Revisited

Area of Science:

• Immunology
• Transplantation Science
• Biomarker Discovery

Background:

• Immunologic responses to cardiac allografts begin pre-transplant and persist, leading to chronic dysfunction.
• Despite advances, acute and chronic rejection significantly impact cardiac allograft and patient survival.

Purpose of the Study:

• To summarize molecular mechanisms of inflammatory responses in heart transplantation.
• To review novel therapeutic approaches and diagnostic/prognostic biomarkers for immunological complications.

Main Methods:

• Review of recent findings on molecular mechanisms of inflammation in heart transplantation.
• Summary of therapeutic targets and biomarker candidates.
• Overview of prognostic and diagnostic biomarkers.

Main Results:

• Immune cells, cytokines, and adhesion molecules are potential therapeutic targets for alloimmune responses.
• Molecules like natriuretic peptides, troponins, and cell-free DNA are proposed biomarkers for cardiac transplant rejection.
• Recent developments offer insights into immunopathogenesis and potential treatments.

Conclusions:

• Peripheral blood biomarkers are suitable for non-invasive, low-cost early diagnosis of post-transplant complications.
• Biomarkers can facilitate convenient follow-up of cardiac transplant recipients.
• Early detection and monitoring are crucial for improving patient outcomes.